Renaissance Capital logo

Cardiovascular diagnostics company Lantheus Holdings postpones IPO

July 31, 2014

Lantheus Holdings, which sells medical imaging agents used in the diagnosis of cardiovascular diseases, postponed its IPO on Wednesday, citing poor market conditions. The North Billerica, MA-based company was founded in 1956 and booked $286 million in sales for the 12 months ended 3/31/2014. Lantheus Holdings initially filed confidentially on 3/25/2014. Citi and Jefferies & Co. were set to be the joint bookrunners on the deal.